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Recombinant cystatin C producing clones were isolated from a human placenta llgtl 1 cDNA library. The 
cDNA insert of one of the clones, containing 777 base pairs, encodes the complete mature cystatin C (120 
amino acids) and a hydr*ophobic leader sequence of 26 amino acids, indicating an extracellular function 
of the inhibitor. The deduced protein sequence confirms the protein sequence of cystatin C isolated from 
human urine, but differs in one position from the sequence of the cystatin C fragment deposited as amyloid 
in hereditary cerebral hemorrhage with amyloidosis. 
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Cysteine proteinases participate in the intra- 
cce%$raT cara’Dti>srn D5 ;DrD&n~ and >ai&t> 511, 
proteolytic processing of prohormones [2], extra- 
cellular breakdown of collagen [3] and penetration 
05 norma tissues by makgnannt c&s 58 and PlproY~ 
ia?& asso +r rn&~~~armm% >5>. T?&K *y%5Q- 
logical activity is regulated by specific protein 
i&ir+JiUJrs whic?l reccrl@ were ?ovnd 10 &%rle a 
new superfamily of proteins called the cystatin 
superfami>g I@. The high-b& cyst&ins, or 
kininogens, are heavily glycosylated, their mRNAs 
code for hydrophobic leader sequences [7,8], and 
one of their key functions is therefore assumed to 
be extracellular inhibition of cysteine proteinases. 
Several of the low-M, cystatins characterized have 
also been reported to occur in extracellular fluids 
[9]. However, the low-M, cystatins are not 
glycosylated, and since no mRNAs for this group 
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of inhibitors have been described, it has not been 
ascertained whether any of these are genuine extra- 
cellular inhibitors. The present work was under- 
taken to t>atint tke ~D~~ti~~ D5 +& rn%?r+& 5or 
cystatin C which has the highest concentration of 
all known low-M, cystatins in most human extra- 
c&%x %ui&s invts\iga%& 59) ant5 which #rays an 
irn~&z& r&e in t&? pa~&_@r&~~ 0% 
hereditary cerebral hermorrhage with amyloidosis 
11%13). 7%~ amino acid segaence 02 cy&&in C 
isolated from human urine [13,14] was recently 
PeppW$ed tD be hDLQdDgD2B Wi&’ C-HZ2-7&‘S DRCD- 
gene products 1151. 
2. MATERIALS AND METHODS 
The construction of a human prostate cDNA 
library has previously been described [16]. hgtll 
cDNA libraries made from human placenta and 
liver mRNA were generous gifts from Drs Jose 
Milan (La Jolla Cancer Research Foundation) and 
Savio Woo (Baylor College of Medicine, Houston, 
TX), respectively. Affinity purified antibodies 
against cystatin C were prepared by immuno- 
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sorption of a polyclonal rabbit antiserum raised 
against cystatin C isolated from human urine [ 171. 
A mixed oligonucleotide (23-mer) with the se- 
quence AA (T/C)TG(T/C)CC(A/T/C/G)TT- 
(T/C)CA(T/C) GA(T/C)CA(A/G)CC, based on 
the amino acid sequence of human cystatin C 
(amino acids 82-89 [14]), was a kind gift from Dr 
R. Wydro, Integrated Genetics. 
2.1. Isolation and analysis of cDNA clones 
Recombinant phages were screened at a density 
of 50 000 plaques per 130 mm petri dish with the 
affinity-purified antibodies, according to Young 
and Davis [ 18,191. Bound antibodies were detected 
with alkaline phosphatase-conjugated secondary 
antibodies (Promega Biotechniques), as described 
by the manufacturer. A phages, prepared by the 
plate lysate method, were isolated by centrifuga- 
tion in a CsCl gradient [20]. The DNA was ex- 
tracted by standard methodology [20]. A mixed 
oligonucleotide probe specific for cystatin C was 
hybridized to EcoRI digests of phage DNA in 
Southern blot experiments. Hybridizing cDNA in- 
serts were ligated into EcoRI-linearized pUC18 
plasmid vectors which were subsequently used to 
transform E. coli JM83 cells. Plasmids were 
prepared by the alkaline lysis method [20]. DNA 
sequencing of inserts subcloned in M13mp8 was 
performed using a modified dideoxy chain ter- 
minator technique [21]. The insert of the full- 
length clone C6a was sequenced using the shotgun 
approach [22]. Nucleotide sequences were aligned 
and analysed by computer programmes described 
by Staden [23,24]. 
2.2. Southern blotting and pIaque hybridizations 
DNA was fractionated by electrophoresis in 
0.9% agarose gels and transferred to nitrocellulose 
filters as described [25]. Hybridizations with the 
mixed oligonucleotide probe, 5 ‘-end labelled with 
32P, were carried out at 42°C for 16 h in a solution 
containing 6 x SSC (1 x SSC = 150 mM NaCI/ 
15 mM sodium citrate, pH 7.0), 1 x Denhardt’s 
solution (0.02% bovine serum albumin/0.02% 
polyvinylpyrrolidone/O.02% Ficoll) and 0.05% 
sodium pyrophosphate. Filters were washed with 
several changes of 6 x SSC/O.OS% sodium pyro- 
phosphate at room temperature, then at 37°C for 
1 h and at 50°C for 10 min. Hybridizations with 
nick-translated cDNA were done as described [20]. 
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A commercial kit (Amersham) was used for the 
nick translations, according to the manufacturer’s 
instructions. 
3. RESULTS 
cDNA libraries made from human liver, pros- 
tate and placenta were screened for cystatin C en- 
coding clones. Approx. 1.2 x lo6 recombinants of 
the liver library and 3 x lo5 recombinants of the 
prostate library were screened with both antibodies 
and a mixed oligonucleotide probe. The outcome 
of this screening was negative. In contrast, screen- 
ing of 6 x lo5 recombinants of the placenta library 
yielded nine clones reacting with the antibody. 
Three of these clones, designated C5, C6a and 
C12, were further processed. Their inserts of about 
800, 800 and 700 base pairs, respectively, hybrid- 
ized specifically in Southern blot experiments to a 
mixed oligonucleotide constructed from protein se- 
quence data. Sequencing of inserts from clones 
C6a and Cl2 subcloned in EcoRI-digested 
M13mp8 revealed that the inserts shared the same 
3 ’ sequence, containing the polyadenylation signal 
AATAAA. The entire sequence of both strands of 
the clone C6a cDNA insert was determined by se- 
quencing randomly generated overlapping frag- 
ments subcloned in M13mp8. Each nucleotide was 
determined on average 5.63 times. Furthermore,, 
the data obtained when sequencing the cDNA in- 
-- . 
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Fig.1. Sequencing strategy for the human cystatin C 
cDNA inserts. The inserts of clones Cl2 and C6a were 
sequenced from the ends by the chain terminator 
method. A shotgun sequencing analysis technique was 
used to sequence both DNA strands of the C6a insert. 
Horizontal arrows indicate the direction and extent of 
each sequence analysis. The protein coding region of in- 
sert C6a is boxed, the hatched part showing the region 
coding for the mature protein. 
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GGGCGCAGCGGGTCCTCTCTAT 
95 
CTAGCTCCAGCCTCTCGCCTGCGCCCCACTCCCCGCGTCCCGCTCCTAGCCGACC ATG GCC GGG CCC CTG CGC 
Met Ala Gly Pro Leu Arg 
-26 -21 
155 
GCC CCG CTG CTC CTG CTG GCC ATC CTG GCC GTG GCC CTG GCC GTG AGC CCC GCG GCC GGC 
Ala Pro Leu Leu Leu Leu Ala Ile Leu Ala Val Ala Leu Ala Val Ser Pro Ala Ala Gly 
-1 
215 
TCC AGT CCC GGC AAG CCG CCG CGC CTG GTG GGA GGC CCC ATG GAC GCC AGC GTG GAG GAG 
Ser Ser Pro Gly Lys Pro Pro Arg Leu Val Gly Gly Pro Met Asp Ala Ser Val Glu Glu 
1 20 
275 
GAG GGT GTG CGG CGT GCA CTG GAC TTT GCC GTC GGC GAG TAC AAC AAA GCC AGC AAC GAC 
Glu Gly Val Arg Arg Ala Leu Asp Phe Ala Val Gly Glu Tyr Asn Lys Ala Ser Asn Asp 
40 
335 
ATG TAC CAC AGC CGC GCG CTG CAG GTG GTG CGC GCC CGC AAG CAG ATC GTA GCT GGG GTG 
Met Tyr His Ser Arg Ala Leu Gln Val Val Arg Ala Arg Lys Gln Ile Val Ala Gly Val 
60 
395 
AAC TAC TTC TTG GAC GTG GAG CTG GGC CGA ACC ACG TGT ACC AAG ACC CAG CCC AAC TTG q Asn Tyr Phe Leu Asp Val Glu Leu Gly Arg Thr Thr Cys Thr Lys Thr Gln Pro Asn Leu 
80 
455 
GAC AAC TGC CCC TTC CAT GAC CAG CCA CAT CTG AAA AGG AAA GCA TTC TGC TCT TTC CAG 
Asp Asn Cys Pro Phe His Asp Gln Pro His Leu Lys Arg Lys Ala Phe Cys Ser Phe Gln 
100 
515 
ATC TAC GCT GTG CCT TGG CAG GGC ACA ATG ACC TTG TCG AAA TCC ACC TGT CAG GAC GCC 
Ile Tyr Ala Val Pro Trp Gln Gly Thr Met Thr Leu Ser Lys Ser Thr Cys Gln Asp Ala 
120 
593 
TAG GGGTCTGTACCGGGCTGGCCTGTGCCTATCACCTCTTATGCACACCTCCCACCCCCTGTATTCCCACCCCTGGAC 
672 
TGGTGGCCCCTGCCTTGGGGAAGGTCTCTCCCCATGTGCCTGCACCAGGAGACAGACAGAG~GGCAGCAGGCGGCCTTTG 
751 
TTGCTCAGCAAGGGGCTCTGCCCTCCCTCCTTCCTTCTTGCTTCTCATAGCCCCGGTGTGCGGTGCATACACCCC~ACC 
777 
TCCTGCAATAAAATAGTAGCATCCCC 
Fig.2. Nucleotide and deduced amino acid sequence of clone C6a cDNA encoding human precystatin C. Numbering 
of the nucleotide sequence begins at first nucleotide and proceeds in the 5’ to the 3’ direction. Amino acid numbering 
starts with residue 1 of the mature protein. The amino acid substituted in the cystatin C fragment deposited as amyloid 
in patients with hereditary cerebral hermorrhage with amyloidosis is boxed. The Kozak initiation consensus and the 
polyadenylation signal are underlined. 
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serts of clones C6a and Cl2 from the ends revealed 
that the sequence of the Cl2 insert starts at posi- 
tion 91 of that of C6a (fig.l). 
The C6a insert contains 777 base pairs, including 
77 base pairs of 5 ‘non-coding sequence and 262 
base pairs of 3’non-coding sequence (fig.2). The 
polyadenylation signal AATAAA at positions 
756-761 is followed by 15 nucleotides. A probable 
initiator methionine, located six nucleotides down- 
stream of a stop codon and flanked by sequences 
in agreement with the Kozak initiation consensus 
[26], is coded for by nucleotides 78-80. An open 
reading frame extending from the postulated in- 
itiator methionine to a stop codon, TAG, at posi- 
tions 516-518, encodes the 120 amino acids of 
cystatin C isolated from urine [13,14] and a 
putative hydrophobic signal sequence of 26 amino 
acid residues. 
The cDNA insert of clone C6a was labelled by 
nick translation and used to rescreen 120000 
recombinants of the placenta library. Seven of 
these hybridized to the probe, indicating a frequen- 
cy of cystatin C mRNA in placenta of less than 
0.01%. 
4. DISCUSSION 
Cystatin C has been demonstrated to occur in- 
tracellularly in many neuroendocrine cell types by 
immunohistochemical procedures [ 131, but no 
reports concerning secretion of cystatin C into ex- 
tracellular fluids have been published. However, 
seminal plasma has been determined to have the 
highest concentration of cystatin C of all biological 
fluids investigated so far [9] and recent studies in 
our laboratory indicate that fibroblasts and glial 
cells secrete cystatin C into tissue cultivation 
fluids. We therefore investigated human prostate 
and placenta cDNA libraries, and in addition a 
human liver cDNA library, in an effort to find 
clones carrying inserts complementary to cystatin 
C mRNA. Such clones could only be identified in 
the placenta library, however. 
The amino acid sequence deduced from the 
nucleotide sequence of the cloned cystatin C cDNA 
specifies a precystatin C polypeptide chain con- 
taining not only the amino acid sequence of mature 
cystatin C [ 13,141 but also a hydrophobic leader se- 
quence of 26 amino acids. It is therefore probable 
that cystatin C has a physiological function as a 
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cysteine proteinase inhibitor extracellularly. In- 
deed, a recent investigation of the concentrations 
of all major cystatins, including the kininogens 
and cystatin C, in several human extracellular 
body fluids combined with enzyme kinetic mea- 
surements, indicated that cystatin C could be a 
physiologically important extracellular cysteine 
proteinase inhibitor in several of the investigated 
fluids [9]. 
Cystatin C plays an important role in the patho- 
physiology of hereditary cerebral hermorrhage 
with amyloidosis in which it is deposited as 
amyloid in the walls of the rupturing cerebral 
arteries [9, lo]. The metabolism of cystatin C in 
this disease, which affects young adults, is altered 
[12] and the sequence of the deposited cystatin C 
differs in one position from that originally de- 
scribed for cystatin C isolated from persons 
without the disease [14,27]. It is interesting that the 
cDNA presently described specifies a mature 
cystatin C with an amino acid sequence identical to 
that originally described for ‘normal’ cystatin C 
and that the difference (Gln instead of Leu at posi- 
tion 68) can be explained by a single base substitu- 
tion giving a CAG instead of a CTG sequence at 
positions 357-359. The cloned cDNA for normal 
cystatin C can hopefully be used as a probe in 
elucidating the structure of the gene for the normal 
inhibitor as well as the genetic background to 
hereditary cerebral hemorrhage with amyloidosis. 
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